Alternatives to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
Open Access
- 15 September 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (Supplement) , S184-S190
- https://doi.org/10.1086/519471
Abstract
Vancomycin remains the reference standard for the treatment of systemic infection caused by methicillin-resistant Staphylococcus aureus (MRSA). HowevKeywords
This publication has 41 references indexed in Scilit:
- High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus InfectionsArchives of internal medicine (1960), 2006
- Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care–Associated PneumoniaChest, 2006
- Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983–2002Journal of Antimicrobial Chemotherapy, 2006
- Adaptation of Methicillin-Resistant Staphylococcus aureus in the Face of Vancomycin TherapyClinical Infectious Diseases, 2006
- Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA)International Journal of Antimicrobial Agents, 2005
- Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Linezolid vs Vancomycin *Chest, 2003
- Cerebrospinal Fluid Penetration and Pharmacokinetics of Vancomycin Administered by Continuous Infusion to Mechanically Ventilated Patients in an Intensive Care UnitAntimicrobial Agents and Chemotherapy, 2000
- Penetration of vancomycin into human lung tissueJournal of Antimicrobial Chemotherapy, 1996
- Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patientsAntimicrobial Agents and Chemotherapy, 1993